Product
Ursodeoxycholic Acid
Aliases
ursodeoxycholic acid, Ursodeoxycholic Acid (URSO), URSO, UDCA
Name
ursodeoxycholic acid
5 clinical trials
7 indications
Indication
CirrhosisIndication
BiliaryIndication
Healthy SubjectIndication
Gallbladder PolypIndication
SarcoidosisIndication
Alkaline PhosphataseIndication
Primary Biliary CholangitisClinical trial
A Study of INT 747 (6α-ethyl Chenodeoxycholic Acid (6-ECDCA)) in Combination With Ursodeoxycholic Acid (URSO®, UDCA) in Patients With Primary Biliary CirrhosisStatus: Terminated, Estimated PCD: 2009-08-01
Clinical trial
An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-01-30
Clinical trial
Impact of Ursodeoxycholic Acid Treatment on the Gallbladder Polyp Evolution. Prospective Cohort StudyStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
A Single-center, Open Label, Cross-over Study on the Effects of Ursodeoxycholic Acid (UDCA) in Patients With Hepatic SarcoidosisStatus: Terminated, Estimated PCD: 2022-01-12
Clinical trial
A Prospective, Multi-center, Randomized, Double-blind, Placebo-controlled Study: Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis and an Inadequate Response to Ursodeoxycholic AcidStatus: Recruiting, Estimated PCD: 2024-12-01